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ABSTRACT It is generally accepted that the prothoracic
glands of insects produce ecdysone, which is converted by a
20-monooxygenase in peripheral tissues to the major molting
hormone, 20-hydroxyecdysone. Incubation in vitro of the
prothoracic glands of larval or pupal Manduca sexta in the
presence of a hemolymph protein fraction (HPF) increased the
ecdysteroid content of the medium almost 8-fold. A compara-
ble increase was noted when HPF was added to medium
preconditioned with prothoracic glands but from which the
glands had been removed. We used a differential RIA to show
that a major product of the prothoracic glands in vitro
cross-reacts with antiserum (20-hydroxyecdysone-2-suc-
cinylthyroglobulin amide; H-2) that retains affinity to ecdyster-
olds having a modified A ring. However, this product did not
bind to antiserum (ecdysone-22-succinylthyroglobulin amide;
H-22) that has affity mainly for ecdysteroids modified at the
side chain. We employed radiolabeled precursor studies with
prothoracic glands in vitro and a combination of analytical
techniques (NMR, CD, MS) to demonstrate that the major
ecdysteroid released from the glands is a mixture of 2-
dehydroecdysone and 3-dehydroecdysone (1:2), which is rap-
idly reduced to ecdysone in the presence of HPF. We postulate
that the active component of HPF is 3,(2fi)-forming-3(2)-
ketoecdysteroid reductase. These results may explain several
anomalous observations pertaining to the molting of insect
fragments in the absence of prothoracic glands and suggest a
complex system for the control of insect molting and metamor-
phosis.
It has been more than four decades since it was demon-
strated that the prothoracic glands play a critical role in
insect molting (1) and 33 years since ecdysone, the presumed
molting hormone, was crystallized from extracts of 500 kg of
Bombyx mori pupae (2). Thirteen years ago the relationship
between ecdysone and the prothoracic glands was appar-
ently clarified when it was reported that ecdysone was the
principal product of the prothoracic glands of Manduca
sexta (3) and B. mori larvae (4). In the intervening years, a
central dogma of insect endocrinology has emerged-i.e., a
neuropeptide from the insect brain, prothoracicotropic hor-
mone (P1TH), stimulates the prothoracic glands by way of a
cyclic nucleotide-protein kinase cascade leading to the syn-
thesis and release of ecdysone (5, 6). Ecdysone is then
converted to the principal insect molting hormone, 20-
hydroxyecdysone, by an ecdysone 20-monooxygenase in
tissues peripheral to the prothoracic glands, and a critical
titer of 20-hydroxyecdysone leads to the initiation of the
molting process. We report here the existence of a regula-
tory system that appears to play a critica role in establishing
the ecdysteroid titer so crucial for normal insect molting,
development, and metamorphosis.
MATERIALS AND METHODS
Animals. M. sexta larvae were reared on an artificial diet
at 25-26TC and high humidity (60%) under long-day condi-
tions (light/dark, 16:8) as described (7). Antheraea poly-
phemus pupae were obtained commercially and held at 60C
for 5-9 months.
Hemolymph Fractionation. The antioxidant phenylthio-
urea was added to hemolymph from fifth instar day 6 M.
sexta (Vd larvae or chilled A. polyphemus pupae. The
hemolymph was fractionated on a Sephadex G-15 (Phar-
macia) column to remove low molecular weight moieties,
especially ecdysteroids and tyrosine. The residual immuno-
reactive content of the resulting hemolymph protein fraction
(HPF) (<10 ng/ml) was deducted from data resulting from
addition of HPF to incubation media.
RIA. The rabbit antisera were obtained following immu-
nization with ecdysone-22-succinylthyroglobulin amide (H-
22) or 20-hydroxyecdysone-2-succinylthyroglobulin amide
(H-2). RIA using the H-22 antiserum quantifies compounds
resulting from side-chain phase I oxidations (carbon atom
hydroxylations and/or oxidations of existing hydroxyl
groups) and phase II conjugations (esterification of hydroxyl
groups with organic or inorganic acids), whereas the H-2
antibodies have similar affinities for molecules resulting
from phase I and II metabolism of the A ring (7-11).
Dissection and Culture. Prothoracic glands were dissected
from day 0 (PO) or day 2 (P2) M. sexta pupae. One gland was
incubated at 250C in 50 1y of Grace's medium minus tyrosine
and the contralateral gland was incubated in medium con-
taining HPF (1:1). At various times, 20-,ul aliquots of me-
dium were assayed for immunoreactive (H-22) ecdysteroids.
Twenty microliters of fresh medium (with or without HPF)
was added back to the cultures to keep the volumes con-
stant. Alternatively, prothoracic glands (up to 72 pairs) were
incubated up to 48 hr in proportionately larger volumes of
medium containing streptomycin and gentamycin (each at
100 ,ug/ml) but without HPF. Duplicate 20-,ul aliquots were
removed at intervals and replaced with fresh medium. One
was assayed for immunoreactive (H-22) ecdysteroids di-
rectly, and the other was assayed after treatment with HPF
(20 y.d, 30 min, 250C) followed by heat denaturation (1000C, 2
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min) and centrifugation (5 min, 10,000 x g) to remove
protein.
Chemicals. Ecdysone (Simes, Milan, Italy) was chemically
oxidized (02/Pt) and the product(s) was purified by using
established procedures (12-14): desorption chemical ioniza-
tion (DCI)-MS (NH3) m/z 480 (M + NH4+), negative
DCI-MS (NH3) mle 461 (M - H). An identical oxidation
was performed in 2H20. Tritiated product was obtained by
including [3H]ecdysone (60 Ci/mmol; 1 Ci = 37 GBq; New
England Nuclear).
Chromatography. Prothoracic gland-conditioned medium
or the synthetic oxidation product(s) of ecdysone was ap-
plied to primed C18 Sep-Paks (Waters, Milford, MA), which
were then washed with water, the ecdysteroids were eluted
with methanol, the solvents were evaporated under reduced
pressure, and the residues were subsequently purified by
analytical reverse-phase (RP)-HPLC and normal-phase
(NP)-HPLC (where HP = high-performance) or TLC. Ali-
quots from HPLC or eluted TLC sections were subsequently
analyzed for radioactivity or immunoreactivity (7-9).
Spectroscopy. UV spectra were recorded on a Shimadzu
UV-3000 spectrophotometer. CD analysis utilized a Jasco
J-500A with the sample in methanol. NMR spectra of com-
pounds in 2H20 or methanol-d4 were recorded on a Varian-
40OXT or Bruker WM-250 with either 1H02H (84.67) or
C2H30H (83.30) as reference standard. DCI-MS were taken
on a Ribermag 10-10 instrument with ammonia as ion source.
RESULTS
Physiological Observations. To determine if M. sexta pro-
thoracic glands were stimulated by hemolymph as were
those of B. morn (4), prothoracic glands from PO pupae were
placed in lepidopteran saline, one of the pair acting as
control and its contralateral mate receiving HPF from A.
polyphemus. After 2 hr of incubation, the HPF medium
contained 7.8-fold the amount of ecdysteroids as the control,
as determined with the H-22 RIA. Indeed, it appeared that
ecdysteroid production was accelerated as soon as the
prothoracic glands were transferred to medium containing
HPF (Fig. 1). Similar results were obtained with glands from
V7 larvae and P2 pupae. Although the data suggested that the
HPF contained a factor that stimulated ecdysone production
by the glands, it was also possible that the HPF contained a
substrate that could be enzymatically converted to ecdysone
by the prothoracic glands or that the HPF contained a factor








FIG. 1. Time course of immunoreactive (H-22) ecdysteroid
production by PO prothoracic glands in vitro. M. sexta prothoracic
glands were incubated in lepidopteran saline (-) or saline with HPF
(o). Each point is an average of four separate determinations ± SD.
ecdysteroid produced by the glands into a strongly cross-
reacting ecdysteroid-i.e., ecdysone.
To investigate the above possibilities further, four pairs of
PO prothoracic glands were incubated in 200 ttl of Grace's
medium for 30 min, the glands were removed, and HPF was
added to an aliquot of this preconditioned medium. Mea-
sured by the H-22 RIA, the preconditioned medium con-
tained 1.79 ng of immunoreactive ecdysteroid per gland
before addition of HPF, and 12.97 ng after the addition of
HPF (a 7.25-fold increase in the absence of glandular mate-
rial), thus excluding the possibility that HPF stimulated the
gland directly. Next, the HPF was boiled for 2 min and
centrifuged to remove denatured protein, and the superna-
tant was tested on the preconditioned medium. The heat-
treated material was completely ineffective, suggesting the
presence in the HPF of a heat-labile moiety (enzyme?) that
was responsible for the observed increases in H-22 immu-
noreactive ecdysteroids in the medium. Prior heating of the
prothoracic gland preconditioned medium had no effect on
the HPF-mediated increase in immunoreactive ecdysteroids.
Butanol extraction of preconditioned medium yielded 20.40
ng of H-22 immunoreactive ecdysteroids (the original me-
dium contained 25.46 ng), whereas the solvent residue after
30 min of treatment with HPF contained 108.00 ng, a
5.29-fold increase.
These observations indicate that the prothoracic glands
produce a heat-stable ecdysteroid (X) not recognized by the
H-22 antiserum but which is extractable with butanol and is
converted to an immunoreactive ecdysteroid by a heat-labile
enzyme found in the hemolymph of A. polyphemus. The
factor (enzyme) was also found in the hemolymph of larval
and pupal M. sexta (S.S., J.T.W., D.B.R., and L.I.G.,
unpublished data). The prothoracic glands from several
other species of Lepidoptera also secreted X, and all of these
species also yielded hemolymph capable of converting X to
ecdysone (D.B.R., J.T.W., S.S., and L.I.G., unpublished
data).
The kinetics of ecdysone and X production by prothoracic
glands in vitro are shown in Fig. 2. Glands (P2, 18 pairs) were
incubated in Grace's medium minus tyrosine (1 ml) and
aliquots were analyzed for H-22 immunoreactive ecdyster-
oids prior to and following HPF (from M. sexta pupae)
treatment. Since ecdysone and X comprise >99% of the
ecdysteroids in the medium, the assay measures the cumu-
lative production of ecdysone or, after HPF treatment, the
cumulative production of ecdysone plus X (in ecdysone
equivalents). The difference represents the amount of X in
the medium. From the beginning of incubation, X is pro-
duced rapidly, achieving a concentration 7-fold that of
ecdysone after 1 hr and a maximum at 6 hr, about the time
when production of total ecdysteroids by the glands ap-
proaches zero. Subsequently, the concentration of X de-
clines at a rate of 0.78 ng per gland per hr, the same rate at
which ecdysone accumulates in the medium during this
period. The rate of ecdysone production remains relatively
constant throughout the incubation period, even after the
glands no longer secrete additional ecdysteroid. It is appar-
ent that the primary, if not sole, secretory product of the
glands is X, which is slowly converted to ecdysone so after
long-term incubation, ecdysone is the major ecdysteroid
isolated from the medium. Addition ofHPF from a variety of
developmental stages greatly accelerates this conversion.
Concurrent studies on the biosynthesis of ecdysone by M.
sexta prothoracic glands revealed that [3H]- or [l4C]choles-
terol was converted into labeled 7-dehydrocholesterol in the
glands. In the medium, label was ultimately detected in
ecdysone and in a less polar ecdysteroid that cross-reacted
strongly with the H-2 antibody, but did not cross-react with
the H-22 antibody (9). These data indicate that the uniden-
tified ecdysteroid was modified in the A ring rather than in
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FIG. 2. Time course of cumu-
lative ecdysone and X production
by M. sexta prothoracic glands
(P2) incubated in Grace's medium
minus tyrosine. At each time
point an aliquot of medium was
analyzed by RIA (H-22) prior to
(o) or after incubation (30 min)
with HPF (o). The difference rep-
resents the medium content of X
(x) in ecdysone equivalents.
the side chain (see Materials and Methods). To determine if
X was identical to the aforementioned less polar ecdyste-
roid, 24 pairs of PO prothoracic glands were incubated in 0.7
ml of Grace's medium for 1 hr. The medium then was
analyzed by RP-HPLC. An aliquot (20 Al) of each fraction
from the HPLC was subjected to RIA with the H-22 and H-2
antisera. In addition, a separate aliquot (10 1.l) after solvent
removal was treated with HPF (20 Al in 20 1.l of Grace's
medium minus tyrosine) and subjected to H-2 and H-22 RIA.
Fig. 3 reveals that ecdysone eluted between fractions 34 and
38, and the quantity of ecdysone present was the same as
measured with each antibody and was not affected by the
addition of M. sexta HPF (compare Fig. 3 A and B). In the
absence of HPF an H-2 immunoreactive peak was noted
between fractions 42 and 48 (Fig. 3A), which was not
apparent when the H-22 RIA was utilized (Fig. 3B). After the
addition of HPF, the total H-22-positive ecdysteroid in this
second peak (X) increased from 36.2 ng to 773.0 ng (21.4-
fold), whereas with the H-2 antibody, the ecdysteroid con-
tent of the X peak increased only 2.2-fold. These numbers,
21.4 and 2.2, represent the cross-reactivities ofX relative to
ecdysone with the H-22 and H-2 antisera, respectively. After
HPF treatment of the X peak and subsequent RP-HPLC and
NP-HPLC, immunoreactive material using either the H-22
or H-2 antiserum was found only at the retention time of
ecdysone. Further analysis (RP-HPLC and NP-HPLC) indi-
cated that X was identical to the compound observed when
glands were incubated with labeled cholesterol or 7-dehy-
drocholesterol. In addition, when [3H]X of biosynthetic
origin (1 Ag, 20 mCi/mmol) was treated for 2 hr at room
temperature with HPF (100 ,u in 100 Al of Grace's medium
minus tyrosine) and the product was analyzed by RP-HPLC,
NP-HPLC, and HP-TLC, conversion to [3H]ecdysone was
quantitative. The synthetic [3H]ecdysone oxidation prod-
uct(s) (1,g, 6 mCi/mmol) were also completely converted to
[3H]ecdysone by HPF. Neither ecdysone nor X was present
in extracts of the prothoracic glands prior to or following
their in vitro incubation.
The presence of this previously unrecognized ecdysteroid
in medium in which prothoracic glands had been incubated
was established by four criteria: (i) detection with the H-2
antiserum; (ii) conversion of [3H]cholesterol into X; (iii)
conversion of 7-dehydro[3H]cholesterol into X; and (iv)
absorbance of the X peak at 242 nm. We next turned our
attention to the identification of X.
Chemical Characterization of X. The identical UV data for
ecdysone (I) (Fig. 4) and compound X (Amax = 243 nm, E =
12,400) showed the enone moiety to be intact. The following
data show that X is an =1:2 mixture of 2-dehydroecdysone
(H), and 3-dehydroecdysone (I). A comparison of the CD
spectra of compound X and ecdysone (I) indicated the
presence of an extra saturated carbonyl function-namely,
the CD of I shows Cotton effects (CE) at 330 nm (AE+ 2.3,
,77r*), 250 nm (As-5.2, ir7r*) (15), and 223 nm (Ae+3.4),
whereas that ofX shows CE at 335 nm, 227 nm (nilr* of extra
ketone), 257 nm, and 222 nm. The molecular ion of the mass
spectrum ofX corresponded to the oxidation of one sec-OH
to a carbonyl. From the antibody cross-reactivity data, it
was likely that this oxidation had occurred in the A ring
rather than the side chain.
The 1H NMR spectrum ofX (Fig. 5) showed the presence
of two 7-H signals at 5.90 and 5.85 ppm (ratio 2:1) and twin
peaks due to 22-H (3.55) and 9-H (3.30/3.00); this together
with the difference in chemical shifts of 18-H (80.59 for I,
60.61 for major component in X) and 19-H (80.86 for I, 0.90
for major component in X) suggested that X could be a
mixture of 2- and 3-dehydroecdysone. This was proven by
oxidation of ecdysone with 02/Pt to products, the CD and
NMR data (Fig. 5)11 of which were very similar to those of
mixture X. 3-Dehydroecdysone (M) had been reported to be
the sole oxidation product of ecdysone (12-14), but it was
found that II, as well as Iml, is formed by varying the amount
of catalyst. The ratio of to Iml depends on the catalyst/ec-
dysone ratio; the 1/III ratio approximates that in compound
X when near equal amounts of Pt and ecdysone are em-
ployed.
That the major oxidation product is, in fact, 3-dehydro-
ecdysone (M) is corroborated by measurements of NOE
(Fig. 4), which showed that irradiation of 9-H (63.30, in I)
enhanced the signals of 2-H (84.60, dd, J = 12 and 5 Hz) and
4Hax (82.71, t, J = 13.5), a typical result encountered in
IChemical shifts of pertinent NMR peaks ofH ("a") and III ("b"):
26/27-H (Me), all at 81.06; 21-H (Me), 80.77 d in a and 80.79 d in
b; 18-H (Me), 80.58 s in a and 80.61 s in b; 7-H, 65.85 d in a and
85.90 d in b; 19-H (Me), 80.81 s in a and 80.90 s in b; 9-H, 63.00 m
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ecdysteroids. In contrast, H shows a signal at 3.85 ppm (dd,
J = 12 and 4 Hz, 3-H), the intensity of which is enhanced
upon irrradiation of 9-H (coupled to 7-H at 85.85); a NOE is
also observed between 9-H and 12-Ha (81.54). Molecular
models indicate that ring A in II must adopt a twist boat
conformation to account for those NOE results.
Products II and HI show that the platinum-catalyzed
reaction is a straightforward oxidation. This was corrobo-











FIG. 4. Ecdysone (I), 2-dehydroecdysone(I), and 3-dehydro-
ecdysone (Ill). NMR nuclear Overhauser effects (NOE) (in metha-
nol-d4) are shown in conformational structures II and III- the
number by each arrow denotes the relative % increment of peak
intensities accompanying irradiation.
FIG. 3. RP-HPLC/RIA analysis
of ecdysteroids in medium after in
vitro incubation of M. sexta PO pro-
thoracic glands for 1 hr at 250C. RP-
HPLC utilized a Resolve C18 (5 Sum,
Waters) column and a solvent system
of acetonitrile/20 mM Tris/perchlo-
rate, pH 7.5; 5-95% acetonitrile in 60
min (1 ml/min). (A) Analysis by H-2
antiserum of aliquots of elution frac-
tions prior to (-*--) and after incu-
bation with HPF (. o-). (B) Analysis
by H-22 antiserum of corresponding
aliquots of identical fractions as in A
prior to (-*-) and after incubation
with HPF (*-o--). Fractions 34-38
contain ecdysone; fractions 42-48
contain X. After treatment with HPF,
the X in fractions 42-48 has been
reduced to ecdysone. The increase in
* immunoreactivity of these fractions
a, after HPF addition is due to the
60 greater affinity of both antibody prep-
arations for ecdysone relative to X.
deuterium was incorporated at C-2, -3, 4, and -5-namely,
the production of II and HI does not involve enol interme-
diates. Despite intensive efforts, it has not been possible to
achieve a baseline separation of these two compounds by NP
or RP chromatography.
DISCUSSION
The data presented here indicate that the prothoracic glands
synthesize and secrete 3-dehydroecdysone and 2-dehy-
droecdysone (2:1) and a much smaller amount of ecdysone,
or perhaps no ecdysone at all. Further, 2- and 3-dehydro-
ecdysone are converted to ecdysone by a factor in the
hemolymph, most likely a 3,8(2f3)-forming-3(2)-ketoecdyste-
roid reductase. The analytical chemical data based on NMR,
MS analysis, and CD studies leave little doubt regarding the
nature of the ecdysteroids recovered from the medium in
which prothoracic glands have been incubated.
When the original studies were conducted (3, 4), the
prothoracic glands were mass cultured for up to 15 days to
obtain as much product as possible for chemical identifica-
tion, without making the effort necessary to remove adher-
ing hemolymph. The present data reveal that even under the
best conditions, most of the secreted 2- and 3-dehydroecdy-
sone is converted to ecdysone within 30 min in the presence
of added hemolymph or after 48 hr in prothoracic gland
culture alone. In fact, the possibility exists that the protho-
racic glands actually synthesize no ecdysone at all, but that
the basal lamina (sheath) forming the outer boundary of the
glands, or material (e.g., hemocytes, enzyme) adhering to
this noncellular sheath, have the capacity to reduce 2- and
3-dehydroecdysone to ecdysone. By using an enzymatic
digestion procedure, one can obtain dissociated prothoracic
gland cells devoid of the sheath that respond normally to
PTJ7H by enhanced ecdysteroid synthesis (16). When a
similar paradigm was utilized to investigate the production of
2- and 3-dehydroecdysone, it was revealed that well-washed,
dissociated prothoracic gland cells without basal lamina
produce a much greater ratio of 2- and 3-dehydroecdysone/
ecdysone than intact glands (D.B.R., J.T.W., S.S., and
L.I.G., unpublished data). In the 1970s, we had just begun to
understand the diversity of ecdysteroids in insect tissues
(see ref. 17) and believed that the prothoracic glands must
synthesize and secrete ecdysone and/or 20-hydroxyecdy-
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FIG. 5. NMR spectra of compound X and synthetic oxidation
products of ecdysone, 250 MHz, in 2H20. (Inset A) Detail of
compound X methyl peaks, 400 MHz, in 2H20. (Inset B) Synthetic
product ring A peaks, 250 MHz, in methanol-d4. Compound X and
the synthetic product are 1:2 mixtures of 2-dehydroecdysone (I)
and 3-dehydroecdysone (II); peaks belonging to H and III are
designated by postscripts "a" and "b," respectively. HOD,
'HO2H.
sone. This may have led to the discounting of "spurious"
peaks in the several chromatographic procedures utilized.
On the other hand, a number of past observations support
the present concept that a preecdysone molecule is synthe-
sized by the prothoracic glands. There have been a variety of
observations indicating that insects devoid of prothoracic
glands can molt (18). Perhaps 2- and 3-dehydroecdysone are
sequestered by tissues when the hemolymph ketoreductase
titer is low and manipulations such as surgery release stored
oxoecdysteroids from the sequestration compartment in one
or more tissues into the hemolymph, where they are con-
verted to ecdysone and then to 20-hydroxyecdysone. The
conversion of a prohormone to more active forms by reduc-
tase activity is not unique to insects since, for example, it is
well known that the conversion of testosterone to dihydro-
testosterone is mediated by a 5a-reductase, and the latter
compound is converted to 5a-androstanediol in the presence
of 3-ketoreductase (19). Further it is possible that 3-
dehydroecdysone has hormonal activity itself since it elicits
an ecdysteroid-specific puffing pattern from Drosophila me-
lanogaster salivary gland polytene chromosome (20), albeit
at high concentrations, and just recently it has been reported
that 3-dehydro-20-hydroxyecdysone is an order of magni-
tude more effective than 20-hydroxyecdysone in stimulating
specific protein synthesis in D. melanogaster fat body in
vitro (21).
The data reveal that under in vitro conditions the protho-
racic glands of M. sexta synthesize and secrete 2- and
3-dehydroecdysone as major products. One could argue that
this is a result of the oxidation of ecdysone to 3-dehydro-
ecdysone by an ecdysone oxidase (22, 23). However,
incubation of [3H]ecdysone with prothoracic glands, homo-
genates of prothoracic glands, or dialyzed cytosol from
prothoracic glands under oxidizing conditions yields insig-
nificant quantities of 2- or 3-dehydro[3H]ecdysone (J.T.W.
and L.I.G., unpublished data). It must be emphasized that
our studies have been performed in vitro and although there
is no doubt that M. sexta prothoracic glands synthesize 3-
dehydroecdysone and 2-dehydroecdysone by way of choles-
terol and 7-dehydrocholesterol (9), it has not been demon-
strated that these ecdysteroids are released from the protho-
racic glands in situ. Since a putative (2)3-ketoreductase, or at
least a factor that mediates the conversion of 2- and 3-
dehydroecdysone to ecdysone, exists in the hemolymph,
any of the former compounds would be rapidly reduced to
ecdysone, or perhaps sequestered by peripheral tissues and
are, therefore, not detectable in an analysis of the he-
molymph. Indeed, when [3H]X (2 tg) was injected into M.
sexta pupae and the hemolymph was sampled 10 min later,
only ecdysone and ecdysone metabolites (26-hydroxyecdy-
sone and highly polar conjugates) were identified by RP-
HPLC and NP-HPLC (J.T.W. and L.I.G., unpublished
data).
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